TOMASZEWSKI v. TREVENA, INC. et al

  1. August 03, 2021

    Trevena Settles Opioid Substitute Stock-Drop Suit For $8.5M

    A Pennsylvania federal court has given its final approval to an $8.5 million settlement between Trevena Inc. and investors who say the biopharmaceutical company misled them about federal approvals for a morphine alternative.

  2. June 29, 2021

    Trevena Investors Ink $8.5M Deal Over Painkiller Claims

    A class believed to consist of thousands of Trevena investors asked a Pennsylvania federal judge on Monday to grant final approval of an $8.5 million settlement, which would resolve claims that the biopharmaceutical company misled investors about the approval prospects of a new intravenous painkiller.

  3. August 31, 2020

    Biopharma Co. Trevena Must Face Investors' Stock-Drop Suit

    A Pennsylvania federal judge ruled Friday that a bid by Trevena Inc. to dodge claims it misled investors about the approval prospects of a new intravenous painkiller was improperly based on confidential documents that were not a part of the complaint in the case.

  4. October 03, 2019

    Trevena Says Investors' Key Doc Contradicts Fraud Claims

    Trevena Inc. said in a dismissal bid Wednesday that the investors accusing it of misleading them about interactions with regulators have "seriously misapprehen[ded]" the main document underlying their claims.

  5. May 29, 2019

    2 Firms Named Lead Counsel In Trevena Stock-Drop Suit

    Block & Leviton LLP and Kaufman Coren & Ress LLP were named class counsel in litigation accusing Trevena Inc. of artificially inflating its share value, a Pennsylvania federal judge decided on Wednesday, citing careless errors made by an investor represented by rival attorneys.

  6. March 21, 2019

    Firms Contest Class Counsel Bid In Trevena Investor Suit

    Citing alleged misstatements made by an investor represented by rival attorneys, Block & Leviton LLP and Kaufman Coren & Ress LLP have urged a Pennsylvania federal judge to name them class counsel in litigation accusing Trevena Inc. of artificially inflating its share value.